These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15980915)

  • 1. PHARMAC and tobacco control in New Zealand: two licensed funded options are already available.
    Metcalfe S; Moodie P; McNee W
    N Z Med J; 2005 Jun; 118(1217):U1544; author reply U1544; discussion U1544. PubMed ID: 15980915
    [No Abstract]   [Full Text] [Related]  

  • 2. More on PHARMAC and tobacco control in New Zealand.
    Metcalfe S; Moodie P
    N Z Med J; 2006 Jan; 119(1228):U1837. PubMed ID: 16462938
    [No Abstract]   [Full Text] [Related]  

  • 3. PHARMAC and tobacco control in New Zealand: government policy 'up in smoke'.
    Holt S; Harwood M; Aldington S; Beasley R
    N Z Med J; 2005 Jun; 118(1216):U1502. PubMed ID: 15937536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PHARMAC responds to the RMI's editorial.
    Moodie P; McNee W
    N Z Med J; 2005 Jun; 118(1217):U1527. PubMed ID: 15980901
    [No Abstract]   [Full Text] [Related]  

  • 5. Buproprion, public funding, and smoking cessation.
    Bloomfield A
    N Z Med J; 2005 Jul; 118(1218):U1576. PubMed ID: 16027759
    [No Abstract]   [Full Text] [Related]  

  • 6. Nortriptyline for smoking cessation: a review.
    Hughes JR; Stead LF; Lancaster T
    Nicotine Tob Res; 2005 Aug; 7(4):491-9. PubMed ID: 16085520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Methods and cost effectiveness of nicotine abstinence].
    Górecka D
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():79-82. PubMed ID: 15524024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What's new in nicotine & tobacco research?
    Hébert R
    Nicotine Tob Res; 2005 Dec; 7(6):817-20. PubMed ID: 16298716
    [No Abstract]   [Full Text] [Related]  

  • 9. A cost-effectiveness evaluation of single and combined smoking cessation interventions in Texas.
    Hill A
    Tex Med; 2006 Aug; 102(8):50-5. PubMed ID: 17115560
    [No Abstract]   [Full Text] [Related]  

  • 10. Treating tobacco addiction--nicotine or no nicotine?
    Benowitz NL
    N Engl J Med; 1997 Oct; 337(17):1230-1. PubMed ID: 9337385
    [No Abstract]   [Full Text] [Related]  

  • 11. What's new in nicotine & tobacco research?
    Hebert R
    Nicotine Tob Res; 2008 Jun; 10(6):943-50. PubMed ID: 18584457
    [No Abstract]   [Full Text] [Related]  

  • 12. What's new in nicotine & tobacco research?
    Hébert R
    Nicotine Tob Res; 2007 Dec; 9(12):1245-9. PubMed ID: 18058342
    [No Abstract]   [Full Text] [Related]  

  • 13. Breaking the ties of nicotine dependence.
    Bennett SM; Andrews JO; Heath JH
    Nurse Pract; 2007 Nov; 32(11):36-45; quiz 45-6. PubMed ID: 18075457
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical inquiries. What is the most effective nicotine replacement therapy?
    Diefenbacher LJ; Smith PO; Nashelsky J; Lindbloom E
    J Fam Pract; 2003 Jun; 52(6):492-4. PubMed ID: 12791233
    [No Abstract]   [Full Text] [Related]  

  • 15. New Zealand smoking cessation guidelines.
    McRobbie H; Bullen C; Glover M; Whittaker R; Wallace-Bell M; Fraser T;
    N Z Med J; 2008 Jun; 121(1276):57-70. PubMed ID: 18574510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost effectiveness of pharmacotherapies for smoking cessation: necessary but not sufficient?
    Shanahan M; Doran C; Gates J; Shakeshaft A; Mattick RP
    Appl Health Econ Health Policy; 2003; 2(2):76-8. PubMed ID: 14619277
    [No Abstract]   [Full Text] [Related]  

  • 17. [Quit smoking is not just a matter or will].
    Duquet N
    J Pharm Belg; 2006; 61(4):105-10. PubMed ID: 17263191
    [No Abstract]   [Full Text] [Related]  

  • 18. Tobacco use cessation for adolescents.
    Adelman WP
    Adolesc Med Clin; 2006 Oct; 17(3):697-717; abstract xii. PubMed ID: 17030287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [ABC of smoking cessation. Bupropion and other drugs in non-nicotine therapy].
    Roddy E
    Cas Lek Cesk; 2004; 143(12):863-5. PubMed ID: 15730222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bupropion: risks and benefits.
    Ross S; Williams D
    Expert Opin Drug Saf; 2005 Nov; 4(6):995-1003. PubMed ID: 16255659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.